Fast Company March 11, 2022
Rockley Photonics, whose sensors help power the Apple Watch, is working to deliver a game-changing development in health tech.
A deal between two little-known companies—at least, to the public—could bring to the market something that health experts have for years considered the holy grail of wellness: glucose-monitoring capabilities on wearable tech.
Rockley Photonics, the California-based maker of the biosensors used in Apple devices, announced Thursday a partnership with Medtronic, a medical-device manufacturer headquartered in Minnesota, to scale a health wearable that can detect a bevy of health metrics, including glucose, or sugar, levels. That may sound boring, but being able to detect glucose levels without a blood sample or an implant is a big deal—one that has the potential to...